Hike Medical Secures $22.5 Million to Revolutionize Device-Based Care
August 27, 2026, 3:36 pm
Hike Medical secured $22.5 million in seed and Series A funding. This capital injection will transform device-based care across the nation. The company integrates advanced AI and 3D printing technology. Its platform modernizes the entire medical device supply chain. This covers essential orthotics, prosthetics, and durable medical equipment (DME). Hike's mission: eliminate widespread waste and streamline patient access. The innovative technology automates complex referrals and approvals. It empowers clinicians with intuitive mobile scanning tools. It also features robust in-house 3D print manufacturing capabilities. This vertically integrated system drastically reduces delivery times. It significantly lowers costly remake rates. This substantial investment fuels Hike's expansion. It moves beyond custom insoles to target the broader $100 billion U.S. DME market. Funds support critical hiring and manufacturing scale-up. Hike is engineering human movement. It delivers faster, more accurate patient solutions.
The medical device industry faces immense challenges. An estimated $100 billion annual U.S. market grapples with inefficiencies. Research indicates significant waste. Nearly 60 cents of every dollar spent disappears. This loss stems from remakes, administrative burden, and fraud. Patients often endure weeks of waiting for crucial equipment. Paperwork and complex payer requirements create widespread delays. Access to necessary devices, like diabetic inserts, braces, and prosthetic limbs, suffers. Hike Medical directly addresses these systemic failures. The company seeks to rebuild the broken infrastructure. It promises a new era of efficiency and patient-focused care.
Hike’s integrated platform tackles these issues end-to-end. It connects back-office operations, clinical workflows, and device manufacturing. The system leverages artificial intelligence to automate complex processes. It brings digital precision to device fabrication. This comprehensive approach aims to make essential medical devices readily available. It shortens the wait for millions of Americans.
Three core components define Hike’s strategy. Hike Intelligence employs AI agents. These agents automatically process referrals. They secure approvals and payments. This happens before a patient even sees a doctor. This automation drastically reduces administrative workloads. It frees up clinicians and providers. It cuts down on pre-appointment delays. This component streamlines the initial, often complex, bureaucratic hurdles. It ensures quicker progression to care.
Hike Clinical transforms point-of-care operations. Clinicians use mobile devices for scanning. They document patient needs within a single workflow. This eliminates traditional foam impressions. It removes the need for standalone scanners. The mobile platform captures precise measurements. It supports the production of highly accurate custom devices. This integration simplifies the clinician’s role. It enhances data accuracy. It ensures patient-specific solutions are captured efficiently.
Hike Lab handles device manufacturing. This in-house facility is located in Peoria, Illinois. It boasts America’s largest orthotic 3D print farm. Custom products are manufactured with rapid turnaround. Delivery typically takes about five business days. This capability ensures quality control. It guarantees swift production. It directly links manufacturing to clinical demand. The vertical integration creates a seamless loop from diagnosis to delivery.
Hike initially focused on custom insoles. This served as a proving ground for its technology. The results were transformative. Traditional production times, measured in weeks, shrank to mere days. Remake rates plummeted from one in 15 to an astounding one in 400. This success validated Hike’s approach. It demonstrated the power of AI and 3D printing in medical applications. The company now extends this proven model. It moves beyond insoles to encompass the broader DME market.
The expansion includes a wide range of devices. Diabetic inserts, orthopedic braces, prosthetic limbs, wheelchairs, and cranial helmets are now in scope. Hike seeks to apply its efficient model to these diverse categories. The market for these products is vast. Modernizing their supply chain holds immense potential for patient benefit.
The recent funding round validates Hike’s vision. Saga Ventures led the investment. Max Altman spearheaded their participation. Other notable investors joined the round. Indicator Ventures, Fifth Down Capital, RiverPark Ventures, and strategic partner Orthofeet contributed. Angel investors Sam Blond and former NFL coach Jerod Mayo also provided capital. This diverse group signals strong confidence in Hike’s disruptive model.
This capital injection will fuel aggressive growth. Hike plans to expand its engineering and sales teams. Hiring will concentrate in San Francisco. Manufacturing capacity in Peoria, Illinois, will also increase. The company plans to scale its operations. It will meet the demands of a growing patient base.
Hike recently strengthened its leadership. Jerry Tang joined as Chief Operating Officer. Tang brings significant experience in scaling operations. He previously served as SVP of Global Operations at Flexport. He later held the COO position at Dandy, a digital dental company. His expertise is crucial for managing rapid expansion. He will ensure operational excellence as Hike broadens its reach.
Hike Medical champions a patient-centric philosophy. The company believes no patient should wait weeks for necessary care. Disconnected healthcare systems cause these delays. Hike’s goal is to reconnect these systems. It aims to make device-based care faster and more responsive. It promises a future where technology bridges the gap between need and access. This investment empowers Hike to execute this transformative strategy. It promises a significant impact on healthcare delivery across the United States.
The medical device industry faces immense challenges. An estimated $100 billion annual U.S. market grapples with inefficiencies. Research indicates significant waste. Nearly 60 cents of every dollar spent disappears. This loss stems from remakes, administrative burden, and fraud. Patients often endure weeks of waiting for crucial equipment. Paperwork and complex payer requirements create widespread delays. Access to necessary devices, like diabetic inserts, braces, and prosthetic limbs, suffers. Hike Medical directly addresses these systemic failures. The company seeks to rebuild the broken infrastructure. It promises a new era of efficiency and patient-focused care.
Hike’s integrated platform tackles these issues end-to-end. It connects back-office operations, clinical workflows, and device manufacturing. The system leverages artificial intelligence to automate complex processes. It brings digital precision to device fabrication. This comprehensive approach aims to make essential medical devices readily available. It shortens the wait for millions of Americans.
Three core components define Hike’s strategy. Hike Intelligence employs AI agents. These agents automatically process referrals. They secure approvals and payments. This happens before a patient even sees a doctor. This automation drastically reduces administrative workloads. It frees up clinicians and providers. It cuts down on pre-appointment delays. This component streamlines the initial, often complex, bureaucratic hurdles. It ensures quicker progression to care.
Hike Clinical transforms point-of-care operations. Clinicians use mobile devices for scanning. They document patient needs within a single workflow. This eliminates traditional foam impressions. It removes the need for standalone scanners. The mobile platform captures precise measurements. It supports the production of highly accurate custom devices. This integration simplifies the clinician’s role. It enhances data accuracy. It ensures patient-specific solutions are captured efficiently.
Hike Lab handles device manufacturing. This in-house facility is located in Peoria, Illinois. It boasts America’s largest orthotic 3D print farm. Custom products are manufactured with rapid turnaround. Delivery typically takes about five business days. This capability ensures quality control. It guarantees swift production. It directly links manufacturing to clinical demand. The vertical integration creates a seamless loop from diagnosis to delivery.
Hike initially focused on custom insoles. This served as a proving ground for its technology. The results were transformative. Traditional production times, measured in weeks, shrank to mere days. Remake rates plummeted from one in 15 to an astounding one in 400. This success validated Hike’s approach. It demonstrated the power of AI and 3D printing in medical applications. The company now extends this proven model. It moves beyond insoles to encompass the broader DME market.
The expansion includes a wide range of devices. Diabetic inserts, orthopedic braces, prosthetic limbs, wheelchairs, and cranial helmets are now in scope. Hike seeks to apply its efficient model to these diverse categories. The market for these products is vast. Modernizing their supply chain holds immense potential for patient benefit.
The recent funding round validates Hike’s vision. Saga Ventures led the investment. Max Altman spearheaded their participation. Other notable investors joined the round. Indicator Ventures, Fifth Down Capital, RiverPark Ventures, and strategic partner Orthofeet contributed. Angel investors Sam Blond and former NFL coach Jerod Mayo also provided capital. This diverse group signals strong confidence in Hike’s disruptive model.
This capital injection will fuel aggressive growth. Hike plans to expand its engineering and sales teams. Hiring will concentrate in San Francisco. Manufacturing capacity in Peoria, Illinois, will also increase. The company plans to scale its operations. It will meet the demands of a growing patient base.
Hike recently strengthened its leadership. Jerry Tang joined as Chief Operating Officer. Tang brings significant experience in scaling operations. He previously served as SVP of Global Operations at Flexport. He later held the COO position at Dandy, a digital dental company. His expertise is crucial for managing rapid expansion. He will ensure operational excellence as Hike broadens its reach.
Hike Medical champions a patient-centric philosophy. The company believes no patient should wait weeks for necessary care. Disconnected healthcare systems cause these delays. Hike’s goal is to reconnect these systems. It aims to make device-based care faster and more responsive. It promises a future where technology bridges the gap between need and access. This investment empowers Hike to execute this transformative strategy. It promises a significant impact on healthcare delivery across the United States.